Suchergebnisse - "IgG"

PubPharm (213)

201

Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities

enthalten in: mAbs | 2012

von Chung, S. | Quarmby, V. | Gao, X. | +9

202

Immunopotentiating properties of a multispecific α-anti-idiotype antibody

enthalten in: mAbs | 2012

von Hernández, T. | Mateo de Acosta, C. | Pérez, R.

203

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

enthalten in: mAbs | 2012

von Zheng, Y. | Tesar, D. | Benincosa, L. | +28

204

Monoclonal antibodies directed against human FcRn and their applications

enthalten in: mAbs | 2012

von Christianson, G. | Sun, V. | Akilesh, S. | +3

205

A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting

enthalten in: mAbs | 2012

von Schubert, I. | Kellner, C. | Stein, C. | +8

206

Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice

enthalten in: mAbs | 2012

von Filipe, V. | Jiskoot, W. | Basmeleh, A. | +3

207

A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens

enthalten in: mAbs | 2011

von Moore, G. | Bautista, C. | Pong, E. | +7

208

Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

enthalten in: mAbs | 2011

von Zhang, N. | Liu, L. | Dumitru, C. | +16

209

Engineering the variable region of therapeutic IgG antibodies

enthalten in: mAbs | 2011

von Igawa, T. | Tsunoda, H. | Kuramochi, T. | +3

210

A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting

enthalten in: mAbs | 2011

von Schubert, I. | Kellner, C. | Stein, C. | +9